These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 11156649)

  • 1. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
    Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
    Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis].
    Bolondi L; Gaiani S; Casali A; Serra C; Piscaglia F
    Radiol Med; 1997; 94(1-2):4-7. PubMed ID: 9424649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
    Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
    J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.
    Nouso K; Tanaka H; Uematsu S; Shiraga K; Okamoto R; Onishi H; Nakamura S; Kobayashi Y; Araki Y; Aoki N; Shiratori Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):437-44. PubMed ID: 17683496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
    Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
    Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
    Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
    PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
    Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY
    Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012.
    Gounder PP; Bulkow LR; Meltzer MI; Bruce MG; Hennessy TW; Snowball M; Spradling PR; Adhikari BB; McMahon BJ
    Int J Circumpolar Health; 2016; 75():31115. PubMed ID: 27197711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
    Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
    J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort.
    Paranaguá-Vezozzo DC; Ono SK; Alvarado-Mora MV; Farias AQ; Cunha-Silva M; França JI; Alves VA; Sherman M; Carrilho FJ
    Ann Hepatol; 2014; 13(4):386-93. PubMed ID: 24927609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a surveillance program for early detection of hepatocellular carcinoma.
    Zoli M; Magalotti D; Bianchi G; Gueli C; Marchesini G; Pisi E
    Cancer; 1996 Sep; 78(5):977-85. PubMed ID: 8780534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis.
    Arguedas MR; Chen VK; Eloubeidi MA; Fallon MB
    Am J Gastroenterol; 2003 Mar; 98(3):679-90. PubMed ID: 12650806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.
    Patel D; Terrault NA; Yao FY; Bass NM; Ladabaum U
    Clin Gastroenterol Hepatol; 2005 Jan; 3(1):75-84. PubMed ID: 15645408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.
    Parikh ND; Singal AG; Hutton DW; Tapper EB
    Am J Gastroenterol; 2020 Oct; 115(10):1642-1649. PubMed ID: 32530829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in liver cirrhosis. A prospective study.
    Imberti D; Fornari F; Sbolli G; Buscarini E; Squassante L; Buscarini L
    Scand J Gastroenterol; 1993 Jun; 28(6):540-4. PubMed ID: 7686686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
    Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
    Trevisani F; Santi V; Gramenzi A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
    Am J Gastroenterol; 2007 Nov; 102(11):2448-57; quiz 2458. PubMed ID: 17617210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
    Amarapurkar D; Han KH; Chan HL; Ueno Y;
    J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.